United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund purchased a new position in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 26,131 shares of the company’s stock, valued at approximately $5,370,000.
A number of other institutional investors and hedge funds have also modified their holdings of CAH. Integrated Wealth Concepts LLC increased its stake in Cardinal Health by 6.9% in the first quarter. Integrated Wealth Concepts LLC now owns 4,363 shares of the company’s stock valued at $601,000 after purchasing an additional 280 shares in the last quarter. Jones Financial Companies Lllp increased its stake in Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after purchasing an additional 14,034 shares in the last quarter. Arrowstreet Capital Limited Partnership bought a new stake in Cardinal Health in the second quarter valued at approximately $1,935,000. Cerity Partners LLC increased its stake in Cardinal Health by 17.0% in the second quarter. Cerity Partners LLC now owns 40,426 shares of the company’s stock valued at $6,792,000 after purchasing an additional 5,880 shares in the last quarter. Finally, Nebula Research & Development LLC increased its stake in Cardinal Health by 34.4% in the second quarter. Nebula Research & Development LLC now owns 10,334 shares of the company’s stock valued at $1,736,000 after purchasing an additional 2,646 shares in the last quarter. 87.17% of the stock is owned by institutional investors.
Analysts Set New Price Targets
Several brokerages have commented on CAH. William Blair began coverage on shares of Cardinal Health in a research note on Tuesday, April 28th. They issued an “outperform” rating for the company. Argus upped their target price on shares of Cardinal Health from $232.00 to $248.00 and gave the company a “buy” rating in a research note on Wednesday, February 11th. Wall Street Zen downgraded shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday. Citigroup reduced their price target on shares of Cardinal Health from $249.00 to $245.00 and set a “buy” rating for the company in a report on Friday, May 1st. Finally, Barclays upped their price target on shares of Cardinal Health from $243.00 to $258.00 and gave the company an “overweight” rating in a report on Tuesday, February 24th. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $241.80.
Cardinal Health Stock Down 1.6%
Cardinal Health stock opened at $196.57 on Friday. Cardinal Health, Inc. has a twelve month low of $137.75 and a twelve month high of $233.60. The company has a 50 day moving average of $203.52 and a 200-day moving average of $208.79. The stock has a market capitalization of $46.04 billion, a PE ratio of 30.06, a price-to-earnings-growth ratio of 1.19 and a beta of 0.53.
Cardinal Health (NYSE:CAH – Get Free Report) last announced its earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, topping the consensus estimate of $2.79 by $0.38. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The business had revenue of $60.94 billion during the quarter, compared to analysts’ expectations of $62.10 billion. During the same quarter in the prior year, the company posted $2.35 earnings per share. The firm’s revenue was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Equities analysts anticipate that Cardinal Health, Inc. will post 10.76 EPS for the current fiscal year.
Cardinal Health Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be issued a dividend of $0.5158 per share. The ex-dividend date is Wednesday, July 1st. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 annualized dividend and a yield of 1.0%. Cardinal Health’s dividend payout ratio is currently 31.19%.
About Cardinal Health
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
Further Reading
- Five stocks we like better than Cardinal Health
- MarketBeat Week in Review – 05/25 – 05/29
- Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys
- Salesforce Stock Finds Support as AI Momentum Builds
- Dollar Tree Keeps Winning After Family Dollar Divorce
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
